Melanocytes and keratinocytes have distinct and shared responses to ultraviolet radiation and arsenic

Toxicology Letters

Volumn 224, Issue 3, 2014, Pages 407-415

  Cooper, K L ^a   Yager, J W ^b   Hudson, L G ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Arsenic; Co carcinogenesis; DNA damage; Keratinocytes; Melanocytes; UVR

Indexed keywords

ARSENIC; ARSENIC TRIOXIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; ZINC FINGER PROTEIN;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL TYPE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DNA REPAIR; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; KERATINOCYTE; MELANOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ULTRAVIOLET RADIATION; ZINC FINGER MOTIF;

EID: 84890193578     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2013.11.010     Document Type: Article

References (56)

1. Abdel-Malek Z.A. Development of alpha-melanocortin analogs for melanoma prevention and targeting. Adv. Exp. Med. Biol. 2010, 681:126-132.
2. Ahmed N.U., Ueda M., Nikaido O., Osawa T., Ichihashi M. High levels of 8-hydroxy-2'-deoxyguanosine appear in normal human epidermis after a single dose of ultraviolet radiation. Br. J. Dermatol. 1999, 140:226-231.
3. Beane Freeman L.E., Dennis L.K., Lynch C.F., Thorne P.S., Just C.L. Toenail arsenic content and cutaneous melanoma in Iowa. Am. J. Epidemiol. 2004, 160:679-687.
4. Beyersmann D., Hartwig A. Carcinogenic metal compounds: recent insight into molecular and cellular mechanisms. Arch. Toxicol. 2008, 82:493-512.
5. Chen Y., Graziano J.H., Parvez F., Hussain I., Momotaj H., van Geen A., Howe G.R., Ahsan H. Modification of risk of arsenic-induced skin lesions by sunlight exposure, smoking, and occupational exposures in Bangladesh. Epidemiology 2006, 17:459-467.
6. Chen Y.C., Guo Y.L., Su H.J., Hsueh Y.M., Smith T.J., Ryan L.M., Lee M.S., Chao S.C., Lee J.Y., Christiani D.C. Arsenic methylation and skin cancer risk in southwestern Taiwan. J. Occup. Environ. Med. 2003, 45:241-248.
7. Chervona Y., Arita A., Costa M. Carcinogenic metals and the epigenome: understanding the effect of nickel, arsenic, and chromium. Metallomics 2012, 4:619-627.
8. Ciren P.B., Li Z.Q. Long-term global earth surface ultraviolet radiation exposure derived from ISCCP and TOMS satellite measurements. Agric. Forest Meteorol. 2003, 120:51-68.
9. Cooper K.L., King B.S., Sandoval M.M., Liu K.J., Hudson L.G. Reduction of arsenite-enhanced ultraviolet radiation-induced DNA damage by supplemental zinc. Toxicol. Appl. Pharmacol. 2013, 269:81-88.
10. Cooper K.L., Liu K.J., Hudson L.G. Contributions of reactive oxygen species and mitogen-activated protein kinase signaling in arsenite-stimulated hemeoxygenase-1 production. Toxicol. Appl. Pharmacol. 2007, 218:119-127.
11. Cooper K.L., Liu K.J., Hudson L.G. Enhanced ROS production and redox signaling with combined arsenite and UVA exposure: contribution of NADPH oxidase. Free Radic. Biol. Med. 2009, 47:381-388.
12. Cunha E.S., Kawahara R., Kadowaki M.K., Amstalden H.G., Noleto G.R., Cadena S.M., Winnischofer S.M., Martinez G.R. Melanogenesis stimulation in B16-F10 melanoma cells induces cell cycle alterations, increased ROS levels and a differential expression of proteins as revealed by proteomic analysis. Exp. Cell Res. 2012, 318:1913-1925.
13. Dennis L.K., Lynch C.F., Sandler D.P., Alavanja M.C. Pesticide use and cutaneous melanoma in pesticide applicators in the agricultural heath study. Environ. Health Perspect. 2010, 118:812-817.
14. Ding W., Hudson L.G., Liu K.J. Inorganic arsenic compounds cause oxidative damage to DNA and protein by inducing ROS and RNS generation in human keratinocytes. Mol. Cell Biochem. 2005, 279:105-112.
15. Ding W., Hudson L.G., Sun X., Feng C., Liu K.J. As(III) inhibits ultraviolet radiation-induced cyclobutane pyrimidine dimer repair via generation of nitric oxide in human keratinocytes. Free Radic. Biol. Med. 2008, 45:1065-1072.
16. Ding W., Liu W., Cooper K.L., Qin X.J., de Souza Bergo P.L., Hudson L.G., Liu K.J. Inhibition of poly(ADP-ribose) polymerase-1 by arsenite interferes with repair of oxidative DNA damage. J. Biol. Chem. 2009, 284:6809-6817.
17. Ebert F., Weiss A., Bultemeyer M., Hamann I., Hartwig A., Schwerdtle T. Arsenicals affect base excision repair by several mechanisms. Mutat. Res. 2011, 715:32-41.
18. Gandini S., Sera F., Cattaruzza M.S., Pasquini P., Picconi O., Boyle P., Melchi C.F. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur. J. Cancer 2005, 41:45-60.
19. Germolec D.R., Yang R.S., Ackermann M.F., Rosenthal G.J., Boorman G.A., Blair P., Luster M.I. Toxicology studies of a chemical mixture of 25 groundwater contaminants. II. Immunosuppression in B6C3F1 mice. Fundam. Appl. Toxicol. 1989, 13:377-387.
20. Gilchrist D., Schwarze U., Shields K., MacLaren L., Bridge P.J., Byers P.H. Large kindred with Ehlers-Danlos syndrome type IV due to a point mutation (G571S) in the COL3A1 gene of type III procollagen: low risk of pregnancy complications and unexpected longevity in some affected relatives. Am. J. Med. Genet. 1999, 82:305-311.
21. Graham-Evans B., Cohly H.H., Yu H., Tchounwou P.B. Arsenic-induced genotoxic and cytotoxic effects in human keratinocytes, melanocytes and dendritic cells. Int. J. Environ. Res. Public Health 2004, 1:83-89.
22. Huang C., Ke Q., Costa M., Shi X. Molecular mechanisms of arsenic carcinogenesis. Mol. Cell Biochem. 2004, 255:57-66.
23. IARC Solar and Ultraviolet Radiation 1992, International Agency for Research on Cancer, Lyon, France.
24. Ivanov V.N., Hei T.K. Arsenite sensitizes human melanomas to apoptosis via tumor necrosis factor alpha-mediated pathway. J. Biol. Chem. 2004, 279:22747-22758.
25. Jenkins N.C., Grossman D. Role of melanin in melanocyte dysregulation of reactive oxygen species. Biomed. Res. Int. 2013, 2013:908797.
26. Kadekaro A.L., Chen J., Yang J., Chen S., Jameson J., Swope V.B., Cheng T., Kadakia M., Abdel-Malek Z. Alpha-melanocyte-stimulating hormone suppresses oxidative stress through a p53-mediated signaling pathway in human melanocytes. Mol. Cancer Res. 2012, 10:778-786.
27. Karagas M.R., Stukel T.A., Morris J.S., Tosteson T.D., Weiss J.E., Spencer S.K., Greenberg E.R. Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study. Am. J. Epidemiol. 2001, 153:559-565.
28. King B.S., Cooper K.L., Liu K.J., Hudson L.G. Poly(ADP-ribose) contributes to an association between poly(ADP-ribose) polymerase-1 and xeroderma pigmentosum complementation group A in nucleotide excision repair. J. Biol. Chem. 2012, 287:39824-39833.
29. Kricker A., Armstrong B.K., Goumas C., Litchfield M., Begg C.B., Hummer A.J., Marrett L.D., Theis B., Millikan R.C., Thomas N., Culver H.A., Gallagher R.P., Dwyer T., Rebbeck T.R., Kanetsky P.A., Busam K., From L., Mujumdar U., Zanetti R., Berwick M. Ambient UV, personal sun exposure and risk of multiple primary melanomas. Cancer Causes Control 2007, 18:295-304.
30. Leonardi G., Vahter M., Clemens F., Goessler W., Gurzau E., Hemminki K., Hough R., Koppova K., Kumar R., Rudnai P., Surdu S., Fletcher T. Inorganic arsenic and basal cell carcinoma in areas of Hungary, Romania, and Slovakia: a case-control study. Environ. Health Perspect. 2012, 120:721-726.
31. Maresca V., Flori E., Briganti S., Mastrofrancesco A., Fabbri C., Mileo A.M., Paggi M.G., Picardo M. Correlation between melanogenic and catalase activity in in vitro human melanocytes: a synergic strategy against oxidative stress. Pigment Cell Melanoma Res. 2008, 21:200-205.
32. McNeely S.C., Belshoff A.C., Taylor B.F., Fan T.W., McCabe M.J., Pinhas A.R., States J.C. Sensitivity to sodium arsenite in human melanoma cells depends upon susceptibility to arsenite-induced mitotic arrest. Toxicol. Appl. Pharmacol. 2008, 229:252-261.
33. Melkonian S., Argos M., Pierce B.L., Chen Y., Islam T., Ahmed A., Syed E.H., Parvez F., Graziano J., Rathouz P.J., Ahsan H. A prospective study of the synergistic effects of arsenic exposure and smoking, sun exposure, fertilizer use, and pesticide use on risk of premalignant skin lesions in Bangladeshi men. Am. J. Epidemiol. 2011, 173:183-191.
34. Morton W., Dunnette D. Health effects of environmental arsenic. Arsenic in the Environment, Part II: Human Helath and Ecosystem Effects 1994, 17-34. Wiley, New York. J.O. Nriagy (Ed.).
35. Nishigori C., Hattori Y., Toyokuni S. Role of reactive oxygen species in skin carcinogenesis. Antioxid. Redox Signal. 2004, 6:561-570.
36. Pearce D.C., Dowling K., Sim M.R. Cancer incidence and soil arsenic exposure in a historical gold mining area in Victoria, Australia: a geospatial analysis. J. Expo Sci. Environ. Epidemiol. 2012, 22:248-257.
37. Pfeifer G.P., Besaratinia A. UV wavelength-dependent DNA damage and human non-melanoma and melanoma skin cancer. Photochem. Photobiol. Sci. 2012, 11:90-97.
38. Piatek K., Schwerdtle T., Hartwig A., Bal W. Monomethylarsonous acid destroys a tetrathiolate zinc finger much more efficiently than inorganic arsenite: mechanistic considerations and consequences for DNA repair inhibition. Chem. Res. Toxicol. 2008, 21:600-606.
39. Platanias L.C. Biological responses to arsenic compounds. J. Biol. Chem. 2009, 284:18583-18587.
40. Qin X.J., Hudson L.G., Liu W., Timmins G.S., Liu K.J. Low concentration of arsenite exacerbates UVR-induced DNA strand breaks by inhibiting PARP-1 activity. Toxicol. Appl. Pharmacol. 2008, 232:41-50.
41. Rago R., Mitchen J., Wilding G. DNA fluorometric assay in 96-well tissue culture plates using Hoechst 33258 after cell lysis by freezing in distilled water. Anal. Biochem. 1990, 191:31-34.
42. Rossman T.G., Klein C.B. Genetic and epigenetic effects of environmental arsenicals. Metallomics 2011, 3:1135-1141.
43. Rossman T.G., Uddin A.N., Burns F.J. Evidence that arsenite acts as a cocarcinogen in skin cancer. Toxicol. Appl. Pharmacol. 2004, 198:394-404.
44. Shannon R.L., Strayer D.S. Arsenic-induced skin toxicity. Hum. Toxicol. 1989, 8:99-104.
45. Shi H., Hudson L.G., Ding W., Wang S., Cooper K.L., Liu S., Chen Y., Shi X., Liu K.J. Arsenite causes DNA damage in keratinocytes via generation of hydroxyl radicals. Chem. Res. Toxicol. 2004, 17:871-878.
46. Shi H., Shi X., Liu K.J. Oxidative mechanism of arsenic toxicity and carcinogenesis. Mol. Cell Biochem. 2004, 255:67-78.
47. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012. CA Cancer J. Clin. 2012, 62:10-29.
48. Suzukawa A.A., Vieira A., Winnischofer S.M., Scalfo A.C., Di Mascio P., Ferreira A.M., Ravanat J.L., Martins Dde L., Rocha M.E., Martinez G.R. Novel properties of melanins include promotion of DNA strand breaks, impairment of repair, and reduced ability to damage DNA after quenching of singlet oxygen. Free Radic. Biol. Med. 2012, 52:1945-1953.
49. Tokar E.J., Benbrahim-Tallaa L., Ward J.M., Lunn R., Sams R.L., Waalkes M.P. Cancer in experimental animals exposed to arsenic and arsenic compounds. Crit. Rev. Toxicol. 2010, 40:912-927.
50. Tseng W.P., Chu H.M., How S.W., Fong J.M., Lin C.S., Yeh S. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J. Natl. Cancer Inst. 1968, 40:453-463.
51. Watanabe C., Inaoka T., Kadono T., Nagano M., Nakamura S., Ushijima K., Murayama N., Miyazaki K., Ohtsuka R. Males in rural Bangladeshi communities are more susceptible to chronic arsenic poisoning than females: analyses based on urinary arsenic. Environ. Health Perspect. 2001, 109:1265-1270.
52. Wiencke J.K., Yager J.W., Varkonyi A., Hultner M., Lutze L.H. Study of arsenic mutagenesis using the plasmid shuttle vector pZ189 propagated in DNA repair proficient human cells. Mutat. Res. 1997, 386:335-344.
53. Wnek S.M., Kuhlman C.L., Camarillo J.M., Medeiros M.K., Liu K.J., Lau S.S., Gandolfi A.J. Interdependent genotoxic mechanisms of monomethylarsonous acid: role of ROS-induced DNA damage and poly(ADP-ribose) polymerase-1 inhibition in the malignant transformation of urothelial cells. Toxicol. Appl. Pharmacol. 2011, 257:1-13.
54. Yager J.W., Wiencke J.K. Inhibition of poly(ADP-ribose) polymerase by arsenite. Mutat. Res. 1997, 386:345-351.
55. Zhao L., Chen S., Jia L., Shu S., Zhu P., Liu Y. Selectivity of arsenite interaction with zinc finger proteins. Metallomics 2012, 4:988-994.
56. Zhou X., Sun X., Cooper K.L., Wang F., Liu K.J., Hudson L.G. Arsenite interacts selectively with zinc finger proteins containing C3H1 or C4 motifs. J. Biol. Chem. 2011, 286:22855-22863.